Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-26-039359
Filing Date
2026-04-02
Accepted
2026-04-02 21:00:23
Documents
1
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2611043-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2611043-1_4seq1.xml 4 16826
  Complete submission text file 0001104659-26-039359.txt   19636
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Reporting) CIK: 0001425738 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39071 | Film No.: 26836569

Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address
Green Jeremy (Reporting) CIK: 0001650527 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39071 | Film No.: 26836568

Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Issuer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address C/O MAPLES CORPORATE SERVICES LIMITED PO BOX 309, UGLAND HOUSE GEORGE TOWN, GRAND CAYMAN Cayman Islands 4154899980
RedCo II Master Fund, L.P. (Reporting) CIK: 0001921783 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39071 | Film No.: 26836567